Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

Q: How much expense ratio is charged by Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

The expense ratio for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth, or any other mutual fund, is the yearly fee you pay for managing your investments. As of 10 Mar 2026, the expense ratio charged by Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is typically around 1.4 %. This fee covers fund management, administrative, and other operational costs. It is relatively low compared to actively managed funds, reflecting its direct growth option.

Q: What is the AUM of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

As of 10 Mar 2026, the Assets Under Management (AUM) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is approximately ₹854.0384 crore. The AUM can fluctuate based on market conditions and investor activity. It indicates the total value of assets managed by the fund.

Q: What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

The Net Asset Value (NAV) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is updated daily and reflects the per-unit value of the fund's assets. As of 10 Mar 2026 , the NAV is around undefined per unit, but this value might change based on market performance and fund holdings.

Q: What is the PE and PB ratio of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

The PE ratio for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 42.03 and the PB ratio is 7.71. The PE ratio is calculated by dividing the market price by the earnings per share, whereas the PB ratio is calculated by dividing the stock price by the book value per share.

Q: What is the exit load of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

The exit load for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 0% if units are redeemed within 30 days from the date of investment. After this period, no exit load is applicable. This fee is charged to discourage short-term trading and ensure long-term investment.

Equity

NAV

₹ 34.71

CAGR (3 Years)

25.66%

AUM (Cr)

₹ 854.04

Risk

Very High Risk

About Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be ach

Breakdown of this Fund

Chemicals

2.60%

Debt Others

4.77%

Healthcare

55.73%

Miscellaneous

3.85%

Pharmaceuticals

118.04%

Market Capitalization

Expense Ratio, Exit Load and Tax

Expense Ratio

1.4

Exit Load

Nil

Stamp Duty

0.005% (from July 1st, 2020)

Tax Implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.